TIMOLOL, BRIMONIDINE, AND DORZOLAMIDE 0.5% / 0.2% / 2% OMNI BY OCULAR SCIENCE

USPTO USPTO 2017 ABANDONED - NO STATEMENT OF USE FILED

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The US trademark TIMOLOL, BRIMONIDINE, AND DORZOLAMIDE 0.5% / 0.2% / 2% OMNI BY OCULAR SCIENCE was filed as Word and figurative mark on 05/04/2017 at the U.S. Patent and Trademark Office. The current status of the mark is "ABANDONED - NO STATEMENT OF USE FILED".

Logodesign (Wiener Klassifikation)

#Circles containing inscriptions arranged in circular form #USPTO: 26.17.01 - Straight line(s), band(s) or bar(s), Lines, straight, Bars, straight, Bands, straight #USPTO: 26.17.06 - Lines, diagonal, Diagonal line(s), band(s) or bar(s), Bands, diagonal, Bars, diagonal #USPTO: 26.17.09 - Lines, curved, Bars, curved, Curved line(s), band(s) or bar(s), Bands, curved

Trademark Details Last update: May 15, 2022

Trademark form Word and figurative mark
File reference 87437538
Register number 87437538
Application date May 4, 2017

Trademark owner

12424 Wilshire Blvd., No. 900
90025 Los Angeles
US

Trademark representatives

5535 Westlawn Ave., No. 180 90066 Los Angeles US

goods and services

5 Pharmaceuticals

ID: 13